<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To evaluate the relationship of plasma endothelin-1 (ET-1) levels, a marker of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>, and urinary albumin excretion in patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (DM) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Cross-sectional study was conducted in 279 patients (132 males, mean age: 58.7+/-11.0 years, mean DM duration: 11.3+/-8.1 years) </plain></SENT>
<SENT sid="2" pm="."><plain>Urinary albumin excretion, ET-1, and insulin were measured </plain></SENT>
<SENT sid="3" pm="."><plain>Insulin sensitivity was estimated by homeostasis model assessment (HOMA-ir) index </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: ET-1 was associated with urinary albumin excretion after controlling for age, gender, body mass index, blood pressure, HbA1c test, and total cholesterol (R=0.436; adjusted R(2)=0.190, P&lt;0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, there was a progressive increase in plasma ET-1 levels from patients with normoalbuminuria (n=187, 0.92+/-0.50pg/ml), <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (n=68, 1.13+/-0.52pg/ml) to macroalbuminuria (n=24, 1.93+/-1.10pg/ml, P&lt;0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: There is an independent association of plasma ET-1 levels with urinary albumin excretion </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, plasma ET-1 levels started to increase in the <z:mpath ids='MPATH_458'>normal</z:mpath> values of urinary albumin excretion suggesting that in patients with type 2 DM <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> is already present, in urinary albumin excretion values considered <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
</text></document>